Semler Scientific (OTCMKTS:SMLR) Stock Price Passes Above Fifty Day Moving Average of $33.20

Shares of Semler Scientific, Inc. (OTCMKTS:SMLRGet Rating) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $33.20 and traded as high as $37.89. Semler Scientific shares last traded at $36.96, with a volume of 30,086 shares traded.

Analysts Set New Price Targets

Separately, B. Riley cut Semler Scientific from a “buy” rating to a “neutral” rating and cut their target price for the stock from $60.00 to $45.00 in a research note on Wednesday, November 2nd.

Semler Scientific Price Performance

The firm has a 50 day simple moving average of $33.20 and a 200-day simple moving average of $36.40. The company has a market cap of $252.81 million, a price-to-earnings ratio of 23.69 and a beta of 0.62.

Semler Scientific (OTCMKTS:SMLRGet Rating) last issued its quarterly earnings data on Tuesday, November 1st. The medical equipment provider reported $0.46 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.09. Semler Scientific had a return on equity of 27.92% and a net margin of 23.18%. The business had revenue of $14.05 million during the quarter, compared to analysts’ expectations of $15.04 million.

Institutional Investors Weigh In On Semler Scientific

A number of institutional investors have recently modified their holdings of the company. Allspring Global Investments Holdings LLC grew its stake in shares of Semler Scientific by 107.7% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 32,924 shares of the medical equipment provider’s stock valued at $1,086,000 after buying an additional 17,070 shares in the last quarter. Investment Management of Virginia LLC grew its stake in shares of Semler Scientific by 10.5% in the fourth quarter. Investment Management of Virginia LLC now owns 30,423 shares of the medical equipment provider’s stock valued at $1,004,000 after buying an additional 2,893 shares in the last quarter. Laurus Investment Counsel Inc. grew its stake in shares of Semler Scientific by 4.2% in the fourth quarter. Laurus Investment Counsel Inc. now owns 13,020 shares of the medical equipment provider’s stock valued at $582,353,000 after buying an additional 520 shares in the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in shares of Semler Scientific in the third quarter valued at $2,062,000. Finally, Vanguard Group Inc. grew its stake in Semler Scientific by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 225,514 shares of the medical equipment provider’s stock worth $8,468,000 after purchasing an additional 2,400 shares in the last quarter. 58.94% of the stock is owned by institutional investors and hedge funds.

About Semler Scientific

(Get Rating)

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

See Also

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.